T. Rowe Price Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$193M Buy
1,411,619
+44,939
+3% +$5.52M 0.13% 184
2026
Q1
$161M Buy
1,366,680
+720,558
+112% +$101M 0.11% 187
2025
Q4
$106M Buy
646,122
+74,044
+13% +$11.6M 0.07% 244
2025
Q3
$76.5M Buy
572,078
+12,499
+2% +$1.52M 0.05% 316
2025
Q2
$69.6M Buy
559,579
+298,731
+115% +$38M 0.04% 337
2025
Q1
$33.2M Buy
260,848
+101,791
+64% +$15.7M 0.02% 452
2024
Q4
$22.9M Buy
159,057
+131,347
+474% +$18.8M 0.01% 499
2024
Q3
$4.12M Sell
27,710
-482,906
-95% -$69.2M ﹤0.01% 571
2024
Q2
$64.4M Buy
510,616
+84,102
+20% +$13.2M 0.04% 351
2024
Q1
$78.4M Buy
426,514
+23,152
+6% +$4.41M 0.05% 326
2023
Q4
$72.5M Buy
403,362
+120,080
+42% +$18.7M 0.05% 329
2023
Q3
$45M Buy
283,282
+3,514
+1% +$574K 0.03% 377
2023
Q2
$39.6M Buy
279,768
+223,187
+394% +$35.8M 0.03% 402
2023
Q1
$9.53M Buy
56,581
+8,910
+19% +$1.59M 0.01% 519
2022
Q4
$8.07M Buy
47,671
+4,313
+10% +$782K 0.01% 513
2022
Q3
$8.11M Buy
+43,358
New +$9.14M 0.01% 511

Other funds holding RGEN

T. Rowe Price Investment Management's RGEN Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Repligen (RGEN) stake by 3.3% in Q2 2026, buying an estimated $5.52M and bringing the position to 1,411,619 shares worth $193M. The position accounts for 0.13% of the portfolio, ranked #184.

T. Rowe Price Investment Management first reported a position in RGEN in Q3 2022 and has held it in 16 quarters since. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • T. Rowe Price Investment Management held 1,411,619 shares of Repligen worth $193M as of Q2 2026.
  • T. Rowe Price Investment Management bought 44,939 Repligen shares in Q2 2026, an estimated $5.52M.
  • Repligen made up 0.13% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #184 holding.
  • T. Rowe Price Investment Management first reported a position in Repligen in Q3 2022 and has held it in 16 quarters since.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.